TGF-β prevents phosphate-induced osteogenesis through inhibition of BMP and Wnt/β-catenin pathways.

PubWeight™: 0.84‹?›

🔗 View Article (PMC 3937350)

Published in PLoS One on February 27, 2014

Authors

Fátima Guerrero1, Carmen Herencia1, Yolanda Almadén2, Julio M Martínez-Moreno1, Addy Montes de Oca1, María Encarnación Rodriguez-Ortiz1, Juan M Diaz-Tocados1, Antonio Canalejo3, Mónica Florio4, Ignacio López5, William G Richards4, Mariano Rodriguez1, Escolástico Aguilera-Tejero5, Juan R Muñoz-Castañeda1

Author Affiliations

1: Instituto Maimónides para la Investigación Biomédica (IMIBIC). Hospital Reina Sofía. Universidad de Córdoba, Córdoba, Spain.
2: Lipid and Atherosclerosis Unit. IMIBIC/Reina Sofía University Hospital/University of Córdoba, and CIBER Fisiopatología Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Córdoba, Spain.
3: Departamento de Biología Ambiental y Salud Pública, Universidad de Huelva, Huelva, Spain.
4: Metabolic Disorders Department, Amgen, Inc. One Amgen Center Drive, Thousand Oaks, California, United States of America.
5: Department of Medicina y Cirugía Animal, Universidad de Cordoba, Cordoba, Spain.

Articles cited by this

Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant (2003) 6.15

Phosphate regulation of vascular smooth muscle cell calcification. Circ Res (2000) 5.18

Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells (2004) 4.79

Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest (1993) 4.54

Wnt5a potentiates TGF-β signaling to promote colonic crypt regeneration after tissue injury. Science (2012) 3.45

BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J Bone Miner Res (2003) 3.32

Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. J Clin Invest (2005) 3.00

Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro. Kidney Int (2010) 2.61

Vascular calcification mechanisms. J Am Soc Nephrol (2004) 2.13

The BMP signaling and in vivo bone formation. Gene (2005) 1.82

BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells. Atherosclerosis (2008) 1.80

Transforming growth factor-beta and notch signaling mediate stem cell differentiation into smooth muscle cells. Stem Cells (2010) 1.74

Myocardin enhances Smad3-mediated transforming growth factor-beta1 signaling in a CArG box-independent manner: Smad-binding element is an important cis element for SM22alpha transcription in vivo. Circ Res (2005) 1.62

Vascular smooth muscle cell phenotypic plasticity and the regulation of vascular calcification. J Intern Med (2006) 1.49

BMP-7 is an efficacious treatment of vascular calcification in a murine model of atherosclerosis and chronic renal failure. J Am Soc Nephrol (2003) 1.45

Wnt/β-catenin signaling activates bone morphogenetic protein 2 expression in osteoblasts. Bone (2012) 1.38

Notch and transforming growth factor-beta (TGFbeta) signaling pathways cooperatively regulate vascular smooth muscle cell differentiation. J Biol Chem (2010) 1.38

Bone morphogenetic protein-induced MSX1 and MSX2 inhibit myocardin-dependent smooth muscle gene transcription. Mol Cell Biol (2006) 1.36

Crosstalk between Wnt and bone morphogenic protein signaling: a turbulent relationship. Dev Dyn (2010) 1.33

Loss of TGF-beta or Wnt5a results in an increase in Wnt/beta-catenin activity and redirects mammary tumour phenotype. Breast Cancer Res (2009) 1.29

Autogenous regulation of a network of bone morphogenetic proteins (BMPs) mediates the osteogenic differentiation in murine marrow stromal cells. Bone (2007) 1.25

TGF-β regulates β-catenin signaling and osteoblast differentiation in human mesenchymal stem cells. J Cell Biochem (2011) 1.11

Transforming growth factor β suppresses osteoblast differentiation via the vimentin activating transcription factor 4 (ATF4) axis. J Biol Chem (2012) 1.10

Exposure to uremic serum induces a procalcific phenotype in human mesenchymal stem cells. Arterioscler Thromb Vasc Biol (2011) 1.09

Bone morphogenetic protein-2 enhances osterix gene expression in chondrocytes. J Cell Biochem (2003) 1.03

Tumor necrosis factor-α accelerates the calcification of human aortic valve interstitial cells obtained from patients with calcific aortic valve stenosis via the BMP2-Dlx5 pathway. J Pharmacol Exp Ther (2010) 0.99

Vascular calcification and hypertension: cause and effect. Ann Med (2012) 0.98

Transforming growth factor β1 inhibits bone morphogenic protein (BMP)-2 and BMP-7 signaling via upregulation of Ski-related novel protein N (SnoN): possible mechanism for the failure of BMP therapy? BMC Med (2012) 0.93

In vascular smooth muscle cells paricalcitol prevents phosphate-induced Wnt/β-catenin activation. Am J Physiol Renal Physiol (2012) 0.90

Contribution of VCAF-positive cells to neovascularization and calcification in atherosclerotic plaque development. J Pathol (2007) 0.89

High-phosphate-induced calcification is related to SM22α promoter methylation in vascular smooth muscle cells. J Bone Miner Res (2010) 0.88

Biphasic effects of TGFβ1 on BMP9-induced osteogenic differentiation of mesenchymal stem cells. BMB Rep (2012) 0.84

Interleukin-24 attenuates β-glycerophosphate-induced calcification of vascular smooth muscle cells by inhibiting apoptosis, the expression of calcification and osteoblastic markers, and the Wnt/β-catenin pathway. Biochem Biophys Res Commun (2012) 0.84

Chondro/osteoblastic and cardiovascular gene modulation in human artery smooth muscle cells that calcify in the presence of phosphate and calcitriol or paricalcitol. J Cell Biochem (2010) 0.81

The calcimimetic AMG 641 accelerates regression of extraosseous calcification in uremic rats. Am J Physiol Renal Physiol (2009) 0.81

Blood flow and stem cells in vascular disease. Cardiovasc Res (2013) 0.80